Michael Burdick, MD
Radiation Oncologist
Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma
Dr. Burdick graduated the medical school from the Virginia Commonwealth University School of Medicine. He did his internship at the University of Washington and completed his residency program at the Cleveland Clinic Foundation. He is specialized in Radiation Oncology and board certified in Radiation Oncology. Dr. Burdick has been in practice for more than 11 years and is affiliated with the Good Samaritan Hospital and the San Leandro Hospital. During his career, he also contributed to 9 publications of medical interest.
Virginia Commonwealth University School of Medicine
Medical School
University of Washington
Internship
Cleveland Clinic Foundation
Residency
American Board of Radiology - Radiation Oncology
UCLA Medical Center, Santa Monica
Languages: English/Spanish
(424) 259-6000
1250 16th St
Santa Monica, California 90404
Marginal Recurrence Requiring Salvage Radiotherapy after Stereotactic Body Radiotherapy for Spinal Metastases.
Koyfman, S.A., Djemil, T., Burdick, M.J., Woody, N., Balagamwala, E.H., Reddy, C.A., Angelov, L., Suh, J.H., Chao, S.T.; Int J Radiat Oncol Biol Phys. 2012 May 1.
See more >>External beam radiotherapy followed by 90Y ibritumomab tiuxetan in relapsed or refractory bulky follicular lymphoma.
Burdick, M.J., Neumann, D., Pohlman, B., Reddy, C.A., Tendulkar, R.D., Macklis, R.; Int J Radiat Oncol Biol Phys. 2011 Mar 15.
See more >>Maximum standardized uptake value from staging FDG-PET/CT does not predict treatment outcome for early-stage non-small-cell lung cancer treated with stereotactic body ...
Burdick, M.J., Stephans, K.L., Reddy, C.A., Djemil, T., Srinivas, S.M., Videtic, G.M.; Int J Radiat Oncol Biol Phys. 2010 Nov 15.
See more >>